Parkin deficiency promotes colorectal tumorigenesis and progression through RIPK3-dependent necroptotic inflammation

Zheming Wu; Huaping Xiao; Jake A Kloeber; Yaobin Ouyang; Ping Yin; Jinzhou Huang; Bin Chen; Shouhai Zhu; Jing Lu; Yiqun Han; Xinyi Tu; Sonja Dragojevic; Kuntian Luo; Adrian T Ting; Meng Welliver; Zhenkun Lou

doi:10.1002/cac2.12648

Cancer Communications ›› 2025, Vol. 45 ›› Issue (4) : 406 -410. DOI: 10.1002/cac2.12648

LETTER TO THE JOURNAL

Parkin deficiency promotes colorectal tumorigenesis and progression through RIPK3-dependent necroptotic inflammation

Author information +

History +

PDF

Cite this article

Download citation ▾

Zheming Wu, Huaping Xiao, Jake A Kloeber, Yaobin Ouyang, Ping Yin, Jinzhou Huang, Bin Chen, Shouhai Zhu, Jing Lu, Yiqun Han, Xinyi Tu, Sonja Dragojevic, Kuntian Luo, Adrian T Ting, Meng Welliver, Zhenkun Lou. Parkin deficiency promotes colorectal tumorigenesis and progression through RIPK3-dependent necroptotic inflammation. Cancer Communications, 2025, 45(4): 406-410 DOI:10.1002/cac2.12648

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023; 73(3): 233-254.

[2]	Terzic J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology. 2010; 138(6): 2101-2114 e5.

[3]	Lee SB, Kim JJ, Han SA, Fan Y, Guo LS, Aziz K, et al. The AMPK-Parkin axis negatively regulates necroptosis and tumorigenesis by inhibiting the necrosome. Nat Cell Biol. 2019; 21(8): 940-951.

[4]	Najafov A, Zervantonakis IK, Mookhtiar AK, Greninger P, March RJ, Egan RK, et al. BRAF and AXL oncogenes drive RIPK3 expression loss in cancer. PLoS Biol. 2018; 16(8): e2005756.

[5]	Moriwaki K, Balaji S, McQuade T, Malhotra N, Kang J, Chan FK. The necroptosis adaptor RIPK3 promotes injury-induced cytokine expression and tissue repair. Immunity. 2014; 41(4): 567-578.

[6]	Newton K, Sun X, Dixit VM. Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol Cell Biol. 2004; 24(4): 1464-1469.

[7]	Goldberg MS, Fleming SM, Palacino JJ, Cepeda C, Lam HA, Bhatnagar A, et al. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem. 2003; 278(44): 43628-43635.

[8]	Yuan J, Ofengeim D. A guide to cell death pathways. Nat Rev Mol Cell Biol. 2024; 25(5): 379-395.

[9]	Chiba T, Marusawa H, Ushijima T. Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology. 2012; 143(3): 550-563.

[10]	Perales-Linares R, Leli NM, Mohei H, Beghi S, Rivera OD, Kostopoulos N, et al. Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance. Cancer Res. 2023; 83(21): 3562-3576.